These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3885873)

  • 21. Phenylalanine with UVA for the treatment of vitiligo needs more testing for possible side effects.
    Burkhart CG; Burkhart CN
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):1015. PubMed ID: 10365940
    [No Abstract]   [Full Text] [Related]  

  • 22. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.
    Liu LY; Strassner JP; Refat MA; Harris JE; King BA
    J Am Acad Dermatol; 2017 Oct; 77(4):675-682.e1. PubMed ID: 28823882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy of a novel topical formulation for vitiligo: compared evaluation of different treatment modalities in 149 patients.
    Buggiani G; Tsampau D; Hercogovà J; Rossi R; Brazzini B; Lotti T
    Dermatol Ther; 2012; 25(5):472-6. PubMed ID: 23046028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
    Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
    Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
    Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
    Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial.
    El Mofty M; Bosseila M; Mashaly HM; Gawdat H; Makaly H
    Clin Exp Dermatol; 2013 Dec; 38(8):830-5. PubMed ID: 23551324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
    Abdelghani R; Ahmed NA; Darwish HM
    J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evaluation of a novel topical cream for vitiligo and psoriasis that selectively delivers NB-UVB therapy when exposed to sunlight.
    McCoy J; Goren A; Lotti T
    Dermatol Ther; 2014; 27(2):117-20. PubMed ID: 23952638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
    Bakis-Petsoglou S; Le Guay JL; Wittal R
    Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study.
    Nisticò S; Chiricozzi A; Saraceno R; Schipani C; Chimenti S
    Photomed Laser Surg; 2012 Jan; 30(1):26-30. PubMed ID: 22054204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
    Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
    Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenylalanine and UVA for Vitiligo patients: probability of an effective treatment.
    Reuss S; Weiss C; Bayerl C
    Med Hypotheses; 2006; 67(1):199-200. PubMed ID: 16554122
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of vitiligo with oral 5-methoxypsoralen.
    Hann SK; Cho MY; Im S; Park YK
    J Dermatol; 1991 Jun; 18(6):324-9. PubMed ID: 1939861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches.
    Parsad D; Pandhi R; Dogra S; Kumar B
    J Am Acad Dermatol; 2004 Jan; 50(1):63-7. PubMed ID: 14699367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel topical cream delivers safe and effective sunlight therapy for vitiligo by selectively filtering damaging ultraviolet radiation.
    Goren A; Salafia A; McCoy J; Keene S; Lotti T
    Dermatol Ther; 2014; 27(4):195-7. PubMed ID: 24548413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure.
    Juhlin L; Olsson MJ
    Acta Derm Venereol; 1997 Nov; 77(6):460-2. PubMed ID: 9394983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
    Sapam R; Agrawal S; Dhali TK
    Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors influencing methoxsalen phototoxicity in vitiliginous skin.
    Arora SK; Willis I
    Arch Dermatol; 1976 Mar; 112(3):327-32. PubMed ID: 1259445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitiligo and its treatment.
    el-Mofty AM; Nada MM
    Australas J Dermatol; 1974 Apr; 15(1):15-22. PubMed ID: 4416879
    [No Abstract]   [Full Text] [Related]  

  • 40. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients.
    Linthorst Homan MW; Spuls PI; Nieuweboer-Krobotova L; de Korte J; Sprangers MA; Bos JD; Wolkerstorfer A; van der Veen JP
    J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):690-5. PubMed ID: 21711467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.